| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00926354 Details | 2011-06-21 Interventional | 2 | - | Ammonium trichl… Thrombocytopeni… Chemotherapy In… | Sponsor's considerations - | |||
| NCT00706797 Details | 2011-06-21 Interventional | 4 | 141 | Etanercept Methotrexate Arthritis Arthritis, Rheu… Rheumatoid Arth… | - Following early termination of the study, only disposition of randomized participants, description of demographic data on safety population, and safety analyses were performed. | |||
| NCT01010087 Details | 2011-06-10 Interventional | 2 | 59 | Oseltamivir Influenza, Huma… Influenza A Vir… | Patient population no longer available. - | |||
| NCT00802217 Details | 2011-06-10 Interventional | 1 | - | Capsaicin Healthy | PK results demonstrated no systemic absorption - | |||
| NCT00246298 Details | 2011-06-10 Interventional | 2 | 31 | Epoetin Alfa Anemia HIV | OBI business decision not to complete any additional research in HIV. - | |||
| NCT00210561 Details | 2011-06-10 Interventional | 4 | 22 | Acetaminophen Tramadol Back Pain Low Back Pain | Study was stopped shortly after initiation due to change in strategic direction of the company;
no safety concerns were observed that impacted this decision. - | |||
| NCT01368887 Details | 2011-06-08 Interventional | 2 | - | Calcipotriene Niacin Niacinamide Nicotinic Acids Psoriasis | Sponsor seeking additional financial support before starting the study - | |||
| NCT01096329 Details | 2011-06-08 Interventional | 1 | 16 | Methyltestoster… Testosterone Testosterone 17… Testosterone en… Testosterone un… Sexual Dysfunct… Hypoactive Sexu… | - - | |||
| NCT00748787 2007-005019-25 Details | 2011-06-08 Interventional | 2 | 19 | Calcium polycar… Psyllium Metabolic Syndr… Syndrome | It was very difficult to fulfill the inclusion criteria, therefore the expected time of
inclusion was delayed so much time. - | |||
| NCT00650637 Details | 2011-06-08 Interventional | 3 | 17 | Antidiarrheals Calcium Calcium Carbona… Calcium, Dietar… Lamivudine Lamivudine, zid… Loperamide Nelfinavir Zidovudine Diarrhea | The study was prematurely discontinued due to administrative reasons on August 18, 2003. There
were no safety concerns that led to the decision to terminate. - | |||
| NCT00550004 Details | 2011-06-08 Interventional | 2 | - | Gemcitabine Pancreatic Canc… | - - | |||
| NCT00231634 Details | 2011-06-08 Interventional | 3 | 31 | Topiramate Diabetes Mellit… Diabetes Mellit… Diabetes Mellit… Obesity | Program discontinued - | |||
| NCT00231621 Details | 2011-06-08 Interventional | 3 | 179 | Topiramate Dyslipidemias Hyperlipidemias Hyperlipoprotei… Hypertriglyceri… Hyperlipidemia Obesity | The study was terminated prior to completion to focus on the development of a controlled
release formulation. - | |||
| NCT00034788 Details | 2011-06-08 Interventional | 3 | 84 | Becaplermin Diabetic Foot Diabetic Neurop… Foot Ulcer Skin Ulcer Ulcer | Slow recruitment; Study did not address safety concern raised by European Medicines Agency - | |||
| NCT00646087 Details | 2011-06-06 Interventional | 4 | 0 | Ketamine Depressive Diso… Depressive Diso… Depressive Diso… Treatment Resis… | Pilot study determined that this study would not be feasible. - | |||
| NCT00993421 Details | 2011-06-03 Interventional | 2 | 343 | Metoprolol Sibutramine Overweight Weight Loss Obesity | Clinical trial terminated due to results from recent nonclinical studies - | |||
| NCT00539331 Details | 2011-06-01 Interventional | 1 | 6 | Carboplatin Cediranib Paclitaxel Carcinoma, Non-… | - - | |||
| NCT00348894 Details | 2011-06-01 Interventional | 2 | 136 | Reboxetine Peripheral Nerv… Pain | - Study was terminated due to insufficient clinical efficacy observed in previous studies
conducted in postherpetic neuralgia. - | |||
| NCT00333996 Details | 2011-05-30 Interventional | 2/3 | 5 | Dexamethasone Iridocyclitis Uveitis Uveitis, Anteri… Anterior Uveiti… | - - | |||
| NCT00326911 Details | 2011-05-25 Interventional | 2 | 61 | Bevacizumab Cetuximab Gemcitabine Pancreatic Neop… Metastatic Panc… | The planned enrollment was 130 patients and the study was halted prematurely due to lack of
efficacy in both arms. Enrolled patients continued treatment. Accrual on the trial was stopped earlier than planned due to insufficient efficacy in both arms. |